UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:EIF3H-ANKH |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: EIF3H-ANKH | FusionPDB ID: 25846 | FusionGDB2.0 ID: 25846 | Hgene | Tgene | Gene symbol | EIF3H | ANKH | Gene ID | 8667 | 56172 |
Gene name | eukaryotic translation initiation factor 3 subunit H | ANKH inorganic pyrophosphate transport regulator | |
Synonyms | EIF3S3|eIF3-gamma|eIF3-p40 | ANK|CCAL2|CMDJ|CPPDD|HANK|MANK|SLC62A1 | |
Cytomap | 8q23.3-q24.11 | 5p15.2 | |
Type of gene | protein-coding | protein-coding | |
Description | eukaryotic translation initiation factor 3 subunit HeIF-3-gammaeIF3 p40 subuniteukaryotic translation initiation factor 3 subunit 3eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD)eukaryotic translation initiation factor 3, subunit 3 | progressive ankylosis protein homologankylosis, progressive homolog | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | O15372 | Q8IWZ3 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000276682, ENST00000521861, | ENST00000503939, ENST00000284268, ENST00000535119, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 17 X 17 X 5=1445 | 13 X 11 X 7=1001 |
# samples | 23 | 14 | |
** MAII score | log2(23/1445*10)=-2.65136372644367 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(14/1001*10)=-2.83794324189103 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: EIF3H [Title/Abstract] AND ANKH [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | EIF3H(117767905)-ANKH(14716944), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | EIF3H-ANKH seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EIF3H-ANKH seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EIF3H | GO:0006413 | translational initiation | 17581632 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-D7-5577-01A | EIF3H | chr8 | 117767905 | - | ANKH | chr5 | 14716944 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000521861 | EIF3H | chr8 | 117767905 | - | ENST00000284268 | ANKH | chr5 | 14716944 | - | 7017 | 156 | 12 | 623 | 203 |
ENST00000521861 | EIF3H | chr8 | 117767905 | - | ENST00000535119 | ANKH | chr5 | 14716944 | - | 1411 | 156 | 12 | 623 | 203 |
ENST00000276682 | EIF3H | chr8 | 117767905 | - | ENST00000284268 | ANKH | chr5 | 14716944 | - | 7802 | 941 | 767 | 1408 | 213 |
ENST00000276682 | EIF3H | chr8 | 117767905 | - | ENST00000535119 | ANKH | chr5 | 14716944 | - | 2196 | 941 | 767 | 1408 | 213 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000521861 | ENST00000284268 | EIF3H | chr8 | 117767905 | - | ANKH | chr5 | 14716944 | - | 0.002134799 | 0.99786526 |
ENST00000521861 | ENST00000535119 | EIF3H | chr8 | 117767905 | - | ANKH | chr5 | 14716944 | - | 0.001701736 | 0.9982982 |
ENST00000276682 | ENST00000284268 | EIF3H | chr8 | 117767905 | - | ANKH | chr5 | 14716944 | - | 0.002745202 | 0.9972548 |
ENST00000276682 | ENST00000535119 | EIF3H | chr8 | 117767905 | - | ANKH | chr5 | 14716944 | - | 0.003078588 | 0.9969214 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >25846_25846_1_EIF3H-ANKH_EIF3H_chr8_117767905_ENST00000276682_ANKH_chr5_14716944_ENST00000284268_length(amino acids)=213AA_BP=58 MYSRHAQRIPPGKKMASRKEGTGSTATSSSSTAGAAGKGKGKGGSGDSAVKQVQIDGLLCFVMFWTPNVSEKILIDIIGVDFAFAELCVV PLRIFSFFPVPVTVRAHLTGWLMTLKKTFVLAPSSVLRIIVLIASLVVLPYLGVHGATLGVGSLLAGFVGESTMVAIAACYVYRKQKKKM -------------------------------------------------------------- >25846_25846_2_EIF3H-ANKH_EIF3H_chr8_117767905_ENST00000276682_ANKH_chr5_14716944_ENST00000535119_length(amino acids)=213AA_BP=58 MYSRHAQRIPPGKKMASRKEGTGSTATSSSSTAGAAGKGKGKGGSGDSAVKQVQIDGLLCFVMFWTPNVSEKILIDIIGVDFAFAELCVV PLRIFSFFPVPVTVRAHLTGWLMTLKKTFVLAPSSVLRIIVLIASLVVLPYLGVHGATLGVGSLLAGFVGESTMVAIAACYVYRKQKKKM -------------------------------------------------------------- >25846_25846_3_EIF3H-ANKH_EIF3H_chr8_117767905_ENST00000521861_ANKH_chr5_14716944_ENST00000284268_length(amino acids)=203AA_BP=48 MLGKMASRKEGTGSTATSSSSTAGAAGKGKGKGGSGDSAVKQVQIDGLLCFVMFWTPNVSEKILIDIIGVDFAFAELCVVPLRIFSFFPV PVTVRAHLTGWLMTLKKTFVLAPSSVLRIIVLIASLVVLPYLGVHGATLGVGSLLAGFVGESTMVAIAACYVYRKQKKKMENESATEGED -------------------------------------------------------------- >25846_25846_4_EIF3H-ANKH_EIF3H_chr8_117767905_ENST00000521861_ANKH_chr5_14716944_ENST00000535119_length(amino acids)=203AA_BP=48 MLGKMASRKEGTGSTATSSSSTAGAAGKGKGKGGSGDSAVKQVQIDGLLCFVMFWTPNVSEKILIDIIGVDFAFAELCVVPLRIFSFFPV PVTVRAHLTGWLMTLKKTFVLAPSSVLRIIVLIASLVVLPYLGVHGATLGVGSLLAGFVGESTMVAIAACYVYRKQKKKMENESATEGED -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:117767905/chr5:14716944) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
EIF3H | ANKH |
FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03007, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}. | FUNCTION: May play a role as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells. Isoform 2 may possess an antiapoptotic effect and protect cells during normal cell survival through its regulation of caspases. {ECO:0000269|PubMed:16098192}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 348_350 | 337.0 | 493.0 | Topological domain | Extracellular | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 372_403 | 337.0 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 427_429 | 337.0 | 493.0 | Topological domain | Extracellular | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 453_492 | 337.0 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 351_371 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 404_426 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 430_452 | 337.0 | 493.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EIF3H | chr8:117767905 | chr5:14716944 | ENST00000521861 | - | 1 | 8 | 39_173 | 44.0 | 353.0 | Domain | MPN |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 107_131 | 337.0 | 493.0 | Topological domain | Extracellular | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 153_158 | 337.0 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 180_189 | 337.0 | 493.0 | Topological domain | Extracellular | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 1_85 | 337.0 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 211_326 | 337.0 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 132_152 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 159_179 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 190_210 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 327_347 | 337.0 | 493.0 | Transmembrane | Helical | |
Tgene | ANKH | chr8:117767905 | chr5:14716944 | ENST00000284268 | 7 | 12 | 86_106 | 337.0 | 493.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
EIF3H | |
ANKH |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to EIF3H-ANKH |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to EIF3H-ANKH |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |